This program is designed to develop as complete as possible an understanding of the control of transcription of certain genes in lymphoid cells and in a lymphocyte-specific virus. The topics to be investigated are the following questions: 1. What determines the B lymphocyte-specific transcriptional activity of immunoglobulin genes?; 2. How is transcription of T cell receptor (TCR) genes controlled?; 3. What controls IL-2 induction in T lymphocytes?; 4. What controls the induction and repression of terminal deoxynucleotidyl transferase in early lymphoid cells?; 5. What controls induction of human immunodeficiency virus in T lymphocytes?; 6. What is the mechanism of action of the tat gene system in human immunodeficiency virus? Characterization of transcriptional control for these various systems involves, in many cases, the same set of experimental activities. We first use a transient transfection protocol with various cell types to demonstrate that the cloned gene shows transcriptional control. This can be done with the intact gene or with fragments connected to a reporter gene (usually chloramphenicol acetyl transferase). Then deletion analysis can grossly demarcate the important regions. Electrophoretic mobility shift assays with regions to which putative regulatory proteins can bind allow a fine mapping binding sites. Point mutations in these binding sites then show if the sites have regulatory significance. Purification of the proteins followed by cloning can then allow further physical and functional study, especially using in vitro transcriptional systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM039458-01
Application #
3296460
Study Section
Molecular Biology Study Section (MBY)
Project Start
1988-02-01
Project End
1993-01-31
Budget Start
1988-02-01
Budget End
1989-01-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
076580745
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Ramakrishnan, Parameswaran; Yui, Mary A; Tomalka, Jeffrey A et al. (2016) Deficiency of Nuclear Factor-?B c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice. Diabetes 65:2367-79
Ramakrishnan, Parameswaran; Clark, Peter M; Mason, Daniel E et al. (2013) Activation of the transcriptional function of the NF-?B protein c-Rel by O-GlcNAc glycosylation. Sci Signal 6:ra75
Hao, Shengli; Baltimore, David (2013) RNA splicing regulates the temporal order of TNF-induced gene expression. Proc Natl Acad Sci U S A 110:11934-9
Ea, Chee-Kwee; Hao, ShengLi; Yeo, Kok Siong et al. (2012) EHMT1 protein binds to nuclear factor-?B p50 and represses gene expression. J Biol Chem 287:31207-17
Ramakrishnan, P; Kahn, D A; Baltimore, D (2011) Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cells. Cell Death Differ 18:690-9
Ramakrishnan, Parameswaran; Baltimore, David (2011) Sam68 is required for both NF-*B activation and apoptosis signaling by the TNF receptor. Mol Cell 43:167-79
Ea, Chee-Kwee; Baltimore, David (2009) Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci U S A 106:18972-7
Lee, Timothy K; Denny, Elissa M; Sanghvi, Jayodita C et al. (2009) A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide. Sci Signal 2:ra65
Hao, Shengli; Baltimore, David (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10:281-8
Taganov, Konstantin D; Boldin, Mark P; Chang, Kuang-Jung et al. (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103:12481-6

Showing the most recent 10 out of 52 publications